MedPath

Brain Network Characteristics in Patients With Disorders of Consciousness

Conditions
Disorders of Consciousness
Registration Number
NCT05558670
Lead Sponsor
Xijing Hospital
Brief Summary

Simultaneous measurement of the three modalities, functional magnetic resonance imaging (fMRI), positron emission tomography (PET) and electroencephalography (EEG) was proven to be feasible and advantageous in evaluating brain structural and functional (via fMRI), metabolic (via PET) and electrophysiological (via EEG) signatures simultaneously under the same conditions. Investigators use trimodal PET-fMRI-EEG imaging to explore the characteristics of brain network damage in patients with disorders of consciousness(DOC), assess the trajectory of consciousness recovery in a prospective observational cohort study.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Coma, VS/UWS, MCS and EMCS according to diagnostic criteria
  2. Age ≥18 years
  3. Written informed consent obtained
Exclusion Criteria
  1. Patients with contraindications to PET, MRI, EEG examinations or inability to complete PET-fMRI-EEG examinations (presence of ferromagnetic metal implants or hyperthermia)
  2. Hyperglycemia that is difficult to correct
  3. Patients with long-term use of corticosteroids
  4. Patients with coexisting severe systemic disease and limited life expectancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CRS-R total scorePatients in coma after 3 weeks enrolled

The coma recovery scale-revised(CRS-R) total score is used to measure level of consciousness of disorder in enrolled patients. CRS-R consists of six subscales addressing auditory, visual, motor, verbal, communication, and arousal functions.The lowest item on each subscale represents reflexive activity and the highest item represents cognitively mediated behavior. Maximum scores of each subscale are summed to obtain the total score (from 0 to 23).The score for each subscale is based on the presence or absence of a specific behavioral response to a sensory stimulus (higher scores are better).

GOSE scorePatients are followed up for 6 months after enrolled

Glasgow Outcome Scale-Extended(GOSE) score is used to measure the functional limitations of participants. GOSE is a 1-8 point scale (1 = Death, 2 = Vegetative State, 3 = Lower Severe Disability, 4 = Upper Severe Disability, 5 = Lower Moderate Disability, 6 = Upper Moderate Disability, 7 = Lower Good Recovery, and 8 = Upper Good Recovery). Patients with higher scores are more independent.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Xijing hospital

🇨🇳

Xi'an, Shaanxi, China

Xijing hospital
🇨🇳Xi'an, Shaanxi, China
Rong Chen
Contact
18292575563
cmuchenrong@126.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.